NextPlat Approves 1-for-10 Reverse Stock Split
NextPlat announced that its Board of Directors has approved a 1-for-10 reverse stock split of the company's issued and outstanding common stock. The reverse stock split is expected to become effective at 12:01 a.m. Eastern Time on April 6, 2026, with trading on a split-adjusted basis beginning on The Nasdaq Capital Market upon the commencement of trading on Tuesday, April 7, 2026 under the company's existing ticker symbol, "NXPL." At the effective time, every 10 shares of NextPlat's issued and outstanding common stock will automatically be combined into one share of common stock. The reverse stock split will reduce the number of shares of the company's outstanding common stock from 27,026,215 shares to approximately 2,702,621 shares, subject to adjustment for fractional shares. The number of authorized shares of common stock and preferred stock under the company's amended and restated certificate of incorporation, as amended, will not be reduced in connection with the reverse stock split. The reverse stock split was previously approved by the company's stockholders at the special meeting of stockholders held on March 27, 2026, which authorized the Board of Directors to implement a reverse split. The Board determined that implementing the reverse split at this time is appropriate to regain compliance with the minimum bid price requirement for maintaining the listing of the company's common stock on The Nasdaq Capital Market and to broaden potential investor interest.
Trade with 70% Backtested Accuracy
Analyst Views on NXPL
About NXPL
About the author

- AI Technology Deployment: NextPlat's PharmcoRx subsidiary has integrated state-of-the-art AI technology into its pharmacy management system to enhance medication fulfillment efficiency, which is expected to significantly reduce operational costs and improve service quality.
- Process Automation: The new system automates previously manual processes such as pharmacy data entry, faxing, and refill management, creating fully HIPAA-compliant digital workflows that enhance prescription management and fulfillment services for customers.
- Internal Upgrades: The AI software is provided by a pharmacy technology vendor with a large client base in the U.S. and Canada, and is being enhanced in collaboration with PharmcoRx's internal digital transformation team, which is expected to drive efficiency gains across the company's pharmacy operations.
- Strategic Expansion: NextPlat's VP of Healthcare Operations, Birute Norkute, stated that embracing modern technology will facilitate rapid service expansion and the introduction of high-value offerings, thereby strengthening the company's competitive position in the healthcare services market.

- Significant Order Growth: NextPlat's subsidiary GTC has secured over $1.2 million in new IoT product orders in Q1 2026, reflecting strong demand from government and military clients for satellite connectivity solutions, thereby enhancing the company's sales pipeline.
- Key Contract Awarded: GTC recently signed an $820,000 contract to support NATO military customer satellite terminal deployments, which not only boosts the company's market position but also lays the groundwork for future order growth.
- Rising Market Demand: With increasing demand for advanced connectivity solutions, NextPlat's CEO noted that the company's reputation among government and enterprise clients is strengthening, which is expected to benefit the company and drive growth in 2026.
- Healthcare Business Expansion: NextPlat's healthcare business is expanding nationwide beyond Florida, and this strategic move, combined with the rising demand for IoT and satellite connectivity solutions, serves as a key driver for the company's future growth.
- Reverse Stock Split: NextPlat Corp announced a 1-for-10 reverse stock split effective April 13, 2026, reducing outstanding shares from approximately 26.9 million to about 2.7 million, which is expected to enhance per-share value and improve shareholder structure.
- Trading Details: Following the reverse split, the company's common stock will resume trading on the Nasdaq Global Market under the existing ticker symbol 'NXPL' with a new CUSIP number 68557F 308, ensuring a smooth transition for investors to the new capital structure.
- Shareholder Rights Protection: During the reverse split, shareholders entitled to fractional shares will receive cash compensation instead, ensuring that all shareholder rights are preserved and enhancing investor confidence in the company's governance.
- Market Strategy Adjustment: This reverse stock split aims not only to elevate the stock price but also to optimize the capital structure, thereby strengthening the company's competitive position in the e-commerce and healthcare technology sectors, facilitating future business expansion and growth.
- Reverse Stock Split: NextPlat Corp announced a 1-for-10 reverse stock split effective April 13, 2026, which will reduce outstanding shares from approximately 26.9 million to about 2.7 million, aiming to enhance share price and attract more investor interest.
- Exchange Transition: Post-split, the company's stock will resume trading on the Nasdaq Global Market under the existing ticker symbol 'NXPL' with a new CUSIP number 68557F 308, ensuring investors can easily track their holdings.
- Shareholder Rights Protection: During the reverse split, shareholders entitled to fractional shares will receive cash compensation instead, safeguarding their interests and enhancing shareholder confidence in the company's governance.
- Market Strategy Adjustment: This reverse stock split is part of the company's broader strategy to optimize its capital structure, aiming to improve market perception and lay the groundwork for future growth, particularly in the expanding e-commerce and healthcare sectors.
- Reverse Stock Split: NextPlat announced a 1-for-10 reverse stock split effective before market open on April 13, reducing outstanding shares from approximately 26.9 million to about 2.7 million, which is expected to enhance per-share value and improve shareholder returns.
- Trading Continuity: Post-split, NextPlat's stock will continue trading on Nasdaq under the ticker “NXPL” with a new CUSIP number, ensuring investors can easily track their holdings and maintain confidence in the stock's liquidity.
- Cash Compensation Mechanism: The reverse split will not issue fractional shares, with shareholders receiving cash in lieu of fractions, aimed at simplifying the shareholder structure and reducing management complexities associated with fractional shares.
- Market Reaction: Following the reverse split announcement, NextPlat's stock rose 2.22% in after-hours trading to $0.459, indicating a positive market response to the company's capital structure adjustment, which may bolster investor confidence.
- Revenue Decline: NextPlat Corp reported total revenue of approximately $54 million for 2025, an 18% decline from 2024, primarily due to reduced contributions from its healthcare operations, indicating pressure in market competitiveness.
- Healthcare Expansion: The company has successfully expanded its healthcare operations nationwide through a partnership with Health Warehouse, supporting customers in all 50 states, which is expected to create new revenue opportunities for future growth.
- 340B Contract Revenue Surge: The fourth quarter of 2025 saw a 94% increase in 340B contract revenue compared to the third quarter, indicating strong growth potential in this segment that could yield significant profits for the company.
- Effective Cost Control: NextPlat achieved a 25% reduction in operating expenses, resulting in over $2 million in annualized cost savings, enhancing the company's financial flexibility and supporting future investment opportunities.










